Your browser doesn't support javascript.
loading
Clinical characteristics and outcomes of Castleman disease: a multicenter Consortium study of 428 patients with 15-year follow-up.
Liu, Wanying; Cai, Qingqing; Yu, Tiantian; Strati, Paolo; Hagemeister, Frederick B; Zhai, Qiongli; Zhang, Mingzhi; Li, Ling; Fang, Xiaosheng; Li, Jianyong; Sun, Ruifang; Zhang, Shanxiang; Yang, Hanjin; Wang, Zhaoming; Qian, Wenbian; Iwaki, Noriko; Sato, Yasuharu; Oksenhendler, Eric; Xu-Monette, Zijun Y; Young, Ken H; Yu, Li.
Afiliação
  • Liu W; Department of Hematology and Oncology, The Second Affiliated Hospital of NanChang University NanChang, China.
  • Cai Q; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center Guangzhou, China.
  • Yu T; Department of Hematology and Oncology, The Second Affiliated Hospital of NanChang University NanChang, China.
  • Strati P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
  • Hagemeister FB; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
  • Zhai Q; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital Tianjin, China.
  • Zhang M; Department of Medical Oncology, Zhengzhou University Cancer Center Zhengzhou, China.
  • Li L; Department of Medical Oncology, Zhengzhou University Cancer Center Zhengzhou, China.
  • Fang X; Department of Hematology and Oncology, Shandong Cancer Hospital Shandong, China.
  • Li J; Department of Hematology and Oncology, Jiangsu Province Hospital, Nanjing University Nanjing, China.
  • Sun R; Department of Pathology, Shanxi Cancer Hospital Shanxi, China.
  • Zhang S; Department of Pathology, Indiana University School of Medicine Indianapolis, IN, USA.
  • Yang H; Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China.
  • Wang Z; Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China.
  • Qian W; Department of Hematology and Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China.
  • Iwaki N; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University Kanazawa, Japan.
  • Sato Y; Division of Pathophysiology, Okayama University Graduate School of Health Sciences Okayama, Japan.
  • Oksenhendler E; Département d'Immunologie Clinique, Hôpital Saint-Louis Paris, France.
  • Xu-Monette ZY; Division of Hematopathology and Department of Pathology, Duke University Medical Center Durham, NC, USA.
  • Young KH; Division of Hematopathology and Department of Pathology, Duke University Medical Center Durham, NC, USA.
  • Yu L; Duke University Cancer Center Durham, NC, USA.
Am J Cancer Res ; 12(9): 4227-4240, 2022.
Article em En | MEDLINE | ID: mdl-36225639
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Cancer Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Cancer Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China